Polysubstituted benzo[b][1,4] oxazepine derivative and preparation method thereof
A multi-substitution, oxazepine technology, applied in the direction of organic chemistry, can solve the problems that are rarely reported, and achieve the effects of short reaction time, wide substrate range and high yield
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] Preparation of 2,4-diphenylbenzo[b][1,4]oxazepine
[0030]
[0031] (Z)-3-((2-bromophenyl)amino)-1,3-diphenylprop-2-en-1-one 0.5mmol, cesium carbonate 1mmol, N-methyl-2-pyrrolidone 5mL Add it into a 10mL reaction tube, place it in an oil bath at 120°C, and react for 12h. Add appropriate amount of water or sodium chloride solution to stop the reaction, and cool to room temperature. The reaction solution was diluted with ethyl acetate, washed three times with water, and the organic phase was washed with anhydrous Na 2 SO 4 Dry, filter, concentrate, and purify by column chromatography to obtain 121.8 mg of the target product with a yield of 82%. The NMR characterization of this compound is as follows: 1 HNMR (400MHz, CDCl 3 )δ8.01(dd, J=6.6,3.1Hz,2H),7.91(dd,J=6.5,3.2Hz,2H),7.50–7.42(m,7H),7.25–7.19(m,2H),7.13 –7.06(m,1H),6.63(s,1H); 13 CNMR (100MHz, CDCl 3 )δ164.1, 163.2, 151.0, 142.1, 139.7, 133.7, 130.5, 130.3, 128.8, 128.6, 128.4, 128.1, 127.5, 126.2, 125.7,...
Embodiment 2
[0033] Preparation of 9-methyl-2,4-diphenylbenzo[b][1,4]oxazepine
[0034]
[0035] (Z)-3-((2-bromo-3-methylphenyl)amino)-1,3-diphenylprop-2-en-1-one 0.5mmol, potassium hydroxide 1mmol, N,N - Add 3mL of dimethylformamide into a 10mL reaction tube, place in an oil bath at 130°C, and react for 20h. Add appropriate amount of water or sodium chloride solution to stop the reaction, and cool to room temperature. The reaction solution was diluted with ethyl acetate, washed three times with water, and the organic phase was washed with anhydrous Na 2 SO 4 Dried, filtered, concentrated, and purified by column chromatography to obtain 80.9 mg of the target product with a yield of 52%. The NMR characterization of this compound is as follows: 1 HNMR (400MHz, CDCl 3 )δ8.02–7.93(m,2H),7.92–7.79(m,2H),7.52–7.36(m,6H),7.28(d,J=1.4Hz,1H),7.09(t,J=7.6Hz ,1H),7.06–6.98(m,1H),6.55(s,1H),2.25(s,3H); 13 CNMR (100MHz, CDCl 3 )δ164.1, 163.4, 150.3, 142.1, 139.8, 134.4, 130.4, 130.3, 130.1, ...
Embodiment 3
[0037] Preparation of 8-methyl-2,4-diphenylbenzo[b][1,4]oxazepine
[0038]
[0039] (Z)-3-((2-iodo-4-methylphenyl)amino)-1,3-diphenylprop-2-en-1-one 0.5mmol, sodium tert-butoxide 1mmol, N- Add 3mL of methyl-2-pyrrolidone into a 10mL reaction tube, place in an oil bath at 120°C, and react for 12h. Add appropriate amount of water or sodium chloride solution to stop the reaction, and cool to room temperature. The reaction solution was diluted with ethyl acetate, washed three times with water, and the organic phase was washed with anhydrous Na 2 SO 4 Dry, filter, concentrate, and purify by column chromatography to obtain 112.0 mg of the target product with a yield of 72%. The NMR characterization of this compound is as follows: 1 HNMR (400MHz, CDCl 3 )δ8.02–7.97(m,2H),7.93–7.87(m,2H),7.45(dt,J=7.0,2.6Hz,6H),7.34(d,J=8.0Hz,1H),7.02(dd ,J=8.0,1.1Hz,1H),6.90(d,J=1.0Hz,1H),6.60(s,1H),2.32(s,3H); 13 CNMR (100MHz, CDCl 3 )δ163.2, 162.7, 150.5, 139.8, 139.6, 138.7, 133.5, 130....
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com